|1.||Uto, Takuhiro: 2 articles (01/2015 - 01/2014)|
|2.||Edoh, Dominic: 2 articles (01/2015 - 01/2014)|
|3.||Morinaga, Osamu: 2 articles (01/2015 - 01/2014)|
|4.||Shoyama, Yukihiro: 2 articles (01/2015 - 01/2014)|
|5.||Tung, Nguyen Huu: 2 articles (01/2015 - 01/2014)|
|6.||Aning, Abigail: 1 article (01/2015)|
|7.||Appiah-Opong, Regina: 1 article (01/2015)|
|8.||Nyarko, Alexander K: 1 article (01/2015)|
|9.||León-Gonzalez, A J: 1 article (05/2014)|
|10.||Martín-Cordero, C: 1 article (05/2014)|
05/15/2014 - "Since both compounds share similar structure and cytotoxic profile, and curcumin is in clinical trials for the treatment of cancer, our results warrant further studies to evaluate the anticancer potential of hirsutanone."
01/01/2015 - "We investigated the antiproliferative activity of hirsutanone (Hir) and oregonin (Ore) in human cancer cell lines and elucidated their mechanisms of action. "
05/15/2014 - "Our data suggest that, like curcumin, an induction of oxidative stress and topo II-mediated DNA damage may play a role in hirsutanone-induced cancer cell death. "
05/15/2014 - "Pre-treatment with the antioxidants NAC (N-acetylcysteine) and MnTMPyP (Mn(III)tetrakis-(1-methyl-4-pyridyl)porthyrin) reduced this activity, suggesting that reactive oxygen species (ROS) participate in hirsutanone-induced cancer cell death. "
|3.||Colonic Neoplasms (Colon Cancer)
|3.||Reactive Oxygen Species (Oxygen Radicals)
|6.||Mn(III) 5,10,15,20- tetrakis(N- methylpyridinium- 2- yl)porphyrin
|7.||trioctyl phosphine oxide (TOPO)